CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: Involvement of TRAF3 as a common mediator

Oncogene

Volumn 13, Issue 10, 1996, Pages 2243-2254

  Eliopoulos, Aristides G ^a   Dawson, Chris W ^a   Mosialos, George ^b   Floettmann, J Eike ^c   Rowe, Martin ^c   Armitage, Richard J ^d   Dawson, Joanne ^a   Zapata, J M ^e   Kerr, David J ^a   Wakelam, Michael J O ^a   Reed, John C ^e   Kieff, Elliott ^b   Young, Lawrence S ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b HARVARD MEDICAL SCHOOL   (United States)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d AMGEN INC   (United States)

^e BURNHAM INSTITUTE   (United States)

Author keywords

CD40; Epithelial; Fas; LMP1; TNF ; TRAF3

Indexed keywords

CD40 ANTIGEN; CERAMIDE; FAS ANTIGEN; MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CARCINOMA CELL; CONTROLLED STUDY; EPITHELIUM CELL; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIGENS, CD40; APOPTOSIS; CELL DIVISION; CELL SURVIVAL; DRUG SYNERGISM; EPITHELIAL CELLS; HUMANS; PROTEINS; RATS; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS; VIRAL MATRIX PROTEINS;

ALPHAVIRUS; ANIMALIA; HUMAN HERPESVIRUS 4;

EID: 10544246075     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Armitage RJ, Fanslow WC, Strockbine L, Sato TA, Clifford KN, Macduff BM, Anderson DM, Gimpel SD, Davis-Smith T, Maliszewski CR, Clark EA, Smith CA, Grabstein KH, Cosman D and Spriggs MK. (1992). Nature (London), 357, 80-82.
2. Armitage RJ, Tough TW, Macduff BM, Fanslow WC, Spriggs MK, Ramsdell F and Alderson MR. (1993). Eur. J. Immunol., 23, 2326-2331.
3. Banchereau J, Bazan F, Blanchard D, Briere F, Gallizi JP, VanKooten C, Liu YJ, Rousset F and Saeland S. (1994). Annu. Rev. Immunol., 12, 881-922.
4. Boise LH, Gonzalez-Garcia M, Postema CE, Ding LY, Lindsten T, Turka LA, Mao XH, Nunez G and Thompson CB. (1993). Cell, 74, 597-608.
5. Callard RE, Armitage RJ, Fanslow WC and Spriggs MK. (1993). Immunol. Today, 14, 559-564.
6. Cheng G, Cleary AM, Ye Z, Hong DI, Lederman S and Baltimore D. (1995). Science (Wash. DC), 267, 1494-1498.
7. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI and Guild BC. (1995). Nature (London), 374, 733-736.
8. Choi MSK, Boise LH, Gottschalk AR, Quintans J, Thompson CB and Klaus GGB. (1995). Eur. J. Immunol., 25, 1352-1357.
9. Clarke EA and Ledbetter JA. (1986). Proc. Natl. Acad. Sci. USA, 83, 4494-4498.
10. Clarke EA and Ledbetter JA. (1994). Nature (London), 367, 425-428.
11. Dawson CW, Rickinson AB and Young LS. (1990). Nature, 344, 777-780.
12. Eliopoulos AG, Kerr DJ, Herod J, Hodgkins L, Krajewski S, Reed JC and Young LS. (1995). Oncogene, 11, 1217-1228.
13. Farrow SN, White JHM, Martinou I, Raven T, Pun KT, Grinham CJ, Martinou JC and Brown R. (1995). Nature, 374, 731-733.
14. Fernandez A, Fosdick LJ, Marin MC, Diaz C, McDonnell TJ, Ananthaswamy HN and McConkey DJ. (1995). Oncogene, 10, 769-774.
15. Floettmann JE, Ward K, Rickinson AB and Rowe M. Virology., in press.
16. Funakoshi S, Longo DL, Beckwith M, Conley DK, Tsarfaty G, Tsarfaty I, Armitage RJ, Fanslow WC, Spriggs MK and Murphy WJ. (1994). Blood, 83, 2787-2794.
17. Gonzalez AL and Joly E. (1995). TIG, 11, 216-217.
18. Gorczyca W, Gong J, Ardelt B, Traganos F and Darzynkiewicz Z. (1993). Cancer Res., 53, 3186-3192.
19. Grammer AC, Bergman MC, Miura Y, Fujita K, Davis LS and Lipsky PE. (1995). J. Immunol., 154, 4996-5010.
20. Green S, Issemann I and Sheer E. (1988). Nucl. Acids Res., 16, 369.
21. Hammerschmidt W, Sugden B and Baichwal VR. (1989). J. Virol., 63, 2469-2475.
22. Hannun YA and Obeid LM. (1995). TIBS, 20, 73-77.
23. Henderson S, Rowe M, Gregory C, Croom-Carter D. Wang F, Longnecker R, Kieff E and Rickinson AB. (1991). Cell, 65, 1107-1115.
24. Holder MJ, Wang H, Milner AE, Casamayor M, Armitage R, Spriggs MK, Fanslow WC, MacLennan ICM, Gregory CD and Gordon J. (1993). Eur. J. Immunol., 23, 2366-2371.
25. Horner AA, Jabara H, Ramesh N and Geha RS. (1995). J. Exp. Med., 181, 1239-1244.
26. Hu HM, O'Rourke K, Boguski MS and Dixit VM. (1994). J. Biol. Chem., 269, 30069-30072.
27. Huen DS, Henderson SA. Croom-Carter D and Rowe M. (1995). Oncogene, 10, 549-560.
28. Inui S, Kaisho T, Kikutani H, Stamenkovic I, Seed B, Clark EA and Kishimoto T. (1990). Eur. J. Immunol., 20, 1747-1753.
29. Itoh N, Tsujimoto Y and Nagata S. (1993). J. Immunol., 151, 621-627.
30. Jaattela M, Benedict M, Tewari M, Shayman JA and Dixit VM. (1995). Oncogene, 10, 2297-2305.
31. Jain VK and Magrath IT. (1991). Anal. Biochem., 199, 119-124.
32. Katira A, Holder M, Pound JD and Gordon J. (1995). Leukocyte Typing V. Sclossman SF. (eds.) Oxford University Press: Oxford.
33. Kawabe T, Naka T, Yoshida K, Tanaka T, Fujiwara H, Suematsu S, Yoshida N, Kishimoto T and Kikutani H. (1994). Immunity, 1, 167-178.
34. Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR. Tomel LD and Barr PJ. (1995). Nature, 374, 736-739.
35. Lederman S, Yellin MJ, Inghirami G, Lee JJ, Knowles DM and Chess L. (1992). J. Immunol., 149, 3817-3826.
36. Mapara MY, Bargou R, Zugck C, Dohner H, Ustaoglou F, Jonker RR, Krammer PH and Dorken B. (1993). Eur. J. Immunol., 23, 702-708.
37. Mitchell T and Sugden B. (1995). J. Virol., 69, 2968-2976.
38. Morimoto H, Yonehara S and Bonavida B. (1993). Cancer Res., 53, 2591-2596.
39. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C and Kieff E. (1995). Cell, 80, 389-399.
40. Mossman T. (1983). J. Immunol. Meth., 65, 55-63.
41. Nagata S and Golstein P. (1995). Science, 267, 1449-1456.
42. Noelle RJ, Ledbetter JA and Aruffo A. (1992). Immunol. Today, 13, 431-433.
43. Oltvai ZN, Milliman CL and Korsmeyer SJ. (1993). Cell, 74, 609-619.
44. Peng M and Lundgren E. (1992). Oncogene, 7, 1775-1782.
45. Renshaw BR, Fanslow WC, Armitage RJ, Campbell KA, Liggitt D, Wright B, Davison BL and Maliszewski CR. (1994). J. Exp. Med., 180, 1889-1900.
46. Rothe M, Sarma V, Dixit VM and Goeddel DV. (1995). Science, 269, 1424-1427.
47. Rothstein TL, Wang JKM, Panka DJ, Foote LC, Wang Z, Stanger B, Cui H, Ju S and Marshak-Rothstein A. (1995). Nature, 314, 163-165.
48. Ruby J, Bluethmann H, Aguet M and Ramshaw IA. (1995). Nature Med., 1, 437-441.
49. Sato T, Irie S and Reed JC. (1995). FEBS Letters, 358, 113-118.
50. Schulze-Osthoff K. (1994). TICB, 4, 421-426.
51. Smith CA, Farrah T and Goodwin RG. (1994). Cell, 76, 959-962.
52. Stamenkovic I, Clark EA and Seed B. (1989). EMBO J., 8, 1403-1410.
53. Tsujimoto Y. (1989). Proc. Natl. Acad. Sci. USA, 86, 1958-1962.
54. Wang D, Leibowitz D, Wang F, Gregory C, Rickinson A, Larson R, Springer T and Kieff E. (1988). J. Virol., 62, 4173-4184.
55. Wang F, Gregory C, Sample C, Rowe M, Leibowitz D, Murray R, Rickinson A and Kieff E. (1990). J. Virol., 64, 2309-2318.
56. Xu J, Foy TM, Laman JD, Elliot EA, Dun JJ, Waldscmidt TJ, Elsemore J, Noelle RJ and Flavell RA. (1994). Immunity, 1, 423-431.
57. Yonehara S, Ishii A and Yonehara M. (1989). J. Exp. Med., 169, 1747-1756.
58. Young LS, Dawson CW, Brown KW and Rickinson AB. (1989). Int. J. Cancer, 43, 786-794.